Cargando…
Correction to: Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with Treatment‑Refractory Nontuberculous Mycobacterial Lung Disease
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298355/ https://www.ncbi.nlm.nih.gov/pubmed/33871806 http://dx.doi.org/10.1007/s13318-021-00687-z |
| _version_ | 1783726043544158208 |
|---|---|
| author | Rubino, Christopher M. Onufrak, Nikolas J. van Ingen, Jakko Griffith, David E. Bhavnani, Sujata M. Yuen, Dayton W. Mange, Kevin C. Winthrop, Kevin L. |
| author_facet | Rubino, Christopher M. Onufrak, Nikolas J. van Ingen, Jakko Griffith, David E. Bhavnani, Sujata M. Yuen, Dayton W. Mange, Kevin C. Winthrop, Kevin L. |
| author_sort | Rubino, Christopher M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8298355 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82983552021-08-12 Correction to: Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with Treatment‑Refractory Nontuberculous Mycobacterial Lung Disease Rubino, Christopher M. Onufrak, Nikolas J. van Ingen, Jakko Griffith, David E. Bhavnani, Sujata M. Yuen, Dayton W. Mange, Kevin C. Winthrop, Kevin L. Eur J Drug Metab Pharmacokinet Correction Springer International Publishing 2021-04-19 2021 /pmc/articles/PMC8298355/ /pubmed/33871806 http://dx.doi.org/10.1007/s13318-021-00687-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction Rubino, Christopher M. Onufrak, Nikolas J. van Ingen, Jakko Griffith, David E. Bhavnani, Sujata M. Yuen, Dayton W. Mange, Kevin C. Winthrop, Kevin L. Correction to: Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with Treatment‑Refractory Nontuberculous Mycobacterial Lung Disease |
| title | Correction to: Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with Treatment‑Refractory Nontuberculous Mycobacterial Lung Disease |
| title_full | Correction to: Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with Treatment‑Refractory Nontuberculous Mycobacterial Lung Disease |
| title_fullStr | Correction to: Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with Treatment‑Refractory Nontuberculous Mycobacterial Lung Disease |
| title_full_unstemmed | Correction to: Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with Treatment‑Refractory Nontuberculous Mycobacterial Lung Disease |
| title_short | Correction to: Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with Treatment‑Refractory Nontuberculous Mycobacterial Lung Disease |
| title_sort | correction to: population pharmacokinetic evaluation of amikacin liposome inhalation suspension in patients with treatment‑refractory nontuberculous mycobacterial lung disease |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298355/ https://www.ncbi.nlm.nih.gov/pubmed/33871806 http://dx.doi.org/10.1007/s13318-021-00687-z |
| work_keys_str_mv | AT rubinochristopherm correctiontopopulationpharmacokineticevaluationofamikacinliposomeinhalationsuspensioninpatientswithtreatmentrefractorynontuberculousmycobacteriallungdisease AT onufraknikolasj correctiontopopulationpharmacokineticevaluationofamikacinliposomeinhalationsuspensioninpatientswithtreatmentrefractorynontuberculousmycobacteriallungdisease AT vaningenjakko correctiontopopulationpharmacokineticevaluationofamikacinliposomeinhalationsuspensioninpatientswithtreatmentrefractorynontuberculousmycobacteriallungdisease AT griffithdavide correctiontopopulationpharmacokineticevaluationofamikacinliposomeinhalationsuspensioninpatientswithtreatmentrefractorynontuberculousmycobacteriallungdisease AT bhavnanisujatam correctiontopopulationpharmacokineticevaluationofamikacinliposomeinhalationsuspensioninpatientswithtreatmentrefractorynontuberculousmycobacteriallungdisease AT yuendaytonw correctiontopopulationpharmacokineticevaluationofamikacinliposomeinhalationsuspensioninpatientswithtreatmentrefractorynontuberculousmycobacteriallungdisease AT mangekevinc correctiontopopulationpharmacokineticevaluationofamikacinliposomeinhalationsuspensioninpatientswithtreatmentrefractorynontuberculousmycobacteriallungdisease AT winthropkevinl correctiontopopulationpharmacokineticevaluationofamikacinliposomeinhalationsuspensioninpatientswithtreatmentrefractorynontuberculousmycobacteriallungdisease |